English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
腾讯网
11 天
信达生物PD-1/IL-2α靶向抗体完成首个关键注册临床研究首例受试者给药
经济观察网讯 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Senate passes funding bill
Sworn in as Canada's PM
Second protester arrested
Texas measles outbreak
Permanently shuts route
SpaceX launches Crew-10
Laceration hazard recall
Plane engine catches fire
Man hit by motorcade, dies
Top intelligence agency visit
Consumer sentiment drops
‘Ted Lasso’ is coming back
Massive dust storms in Texas
Visits DOJ for speech
Court lifts Trump's DEI block
Coffee creamer recall
To cut 2,000+ jobs
Trump Tower protest
Influential WY senator dies
Senate confirmation hearing
Influencer leaves Australia
Strikes deal with DOGE
March megastorm
Legendary sportswriter dies
FDA, NIH nominees advance
Gold rises to new heights
Teixeira pleads guilty
Wins longest-ever Iditarod
Child abuse images sentence
反馈